Searchable abstracts of presentations at key conferences in endocrinology

ea0050p277 | Neuroendocrinology and Pituitary | SFEBES2017

Copeptin during hypertonic saline infusion in a polyuria/polydipsia syndrome case series

Boot Christopher , James R Andrew , Tsatlidis Vasileios , Gibb Fraser , Green Fiona , Neely R Dermot G

Introduction: Copeptin is the C-terminal fragment of proAVP and provides an alternative measure of AVP secretion. While direct measurement of AVP during hypertonic saline infusion has been recommended as a diagnostic test for diabetes insipidus (DI), the number of reports examining the utility of copeptin in this context is limited. Here we describe a series of cases where measurement of copeptin during saline infusion has contributed to ...

ea0085oc9.5 | Oral Communications 9 | BSPED2022

Raising awareness of the importance of preconception counselling in young people with diabetes

Green Steve , Dublon Victoria , Meso Muriel , Burchem Melanie , Beesley Avril , Ambridge Jade , Smith Madeleine

Introduction: Pregnancy under the age of 19 is considered high-risk1; and a pregnancy with diabetes at this age further increases that risk2,3. With the correct advice and counselling, these risks can be greatly reduced. Here we describe a strategy to raise awareness by addressing this as part of regular clinic visits.Method: Prior knowledge of potential complications of pregnancy was assessed as part of a clinical consultation. Evi...

ea0090p99 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Debilitating post-prandial hypoglycaemia as a sole presentation of coeliac disease responding to gluten free diet and plasma exchange for autoimmune neuromyotonia

Aslam Hina , Green Mark , Clarke Emily , Bujanova Jana , Umer Malik Muhammad

Post-prandial hypoglycaemia (PPH) can be associated with debilitating symptoms. Causes include altered physiology post-bariatric and upper gastrointestinal (GI) surgery and rarely noninsulinoma pancreatogenous hypoglycemia syndrome and insulin antibodies. We present a case of 49y female with no prior GI surgery presenting with debilitating hypoglycaemia with blood glucose falling to 2.8 mmol/l responding to glucose. Freestyle Libre monitoring confirmed hypoglycaemia 2-3 h post...

ea0065oc1.2 | Metabolism and Obesity | SFEBES2019

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism

Green Charlotte , Pramfalk Camilla , Charlton Catriona , Gunn Pippa , Cornfield Thomas , Pavalides Michael , Karpe Fredrik , Hodson Leanne

Background and Aim: Hepatic de novo lipogenesis (DNL) has been implicated in the development of non-alcoholic fatty liver disease (NAFLD). Supplementation with the omega-3 fatty acids (FA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) decreases intrahepatic triacylglycerol (IHTAG) and plasma TAG concentrations, which is suggested to be mediated through changes in hepatic DNL. We investigated the effects of omega-3 FA supplementation on intrahepatic DNL an...

ea0066p17 | Diabetes 1 | BSPED2019

The hospital school as a resource for supporting children with type 1 diabetes during planned admissions

Dublon Victoria , Green Steve , Benitez-castillo Malvina , Colman Gabrielle , Ambridge Jade , Ladha Ruhina

Introduction: Hospital schools can provide structure and learning for young people throughout a planned admission. With guidance, teachers can be a vital resource for assessing the numeracy and literacy skills essential in the management of diabetes. They can also provide a source of valuable pastoral and organisational expertise useful to the diabetes multidisciplinary team (MDT).Method: School teaching, pastoral and planning skills can be used to help ...

ea0049gp69 | Developmental & Protein Endocrinology | ECE2017

5β-reductase (AKR1D1) is a potent regulator of carbohydrate and lipid metabolism and inflammation in human liver

Nikolaou Nikolaos , Gathercole Laura , Green Charlotte , McNeil Catriona , Arlt Wiebke , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic disease. 5β-reductase (AKR1D1) is highly expressed in human liver where it inactivates steroid hormones and catalyzes a fundamental step in bile acid synthesis. Steroid hormones, including glucocorticoids, as well as bile acids are established regulators of metabolic phenotype. We hypothesized that AKR1D1 plays a crucial regulatory role in hepatic metabolic homeostasis. Genetic manipulatio...

ea0044oc5.5 | Diabetes Mellitus and Metabolism | SFEBES2016

5β-reductase (AKR1D1) is a potent regulator of carbohydrate and lipid metabolism in human and rodent liver

Nikolaou Nikolaos , Gathercole Laura , Green Charlotte , McNeil Catriona , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease is the hepatic manifestation of metabolic disease. 5β-reductase (AKR1D1) is highly expressed in human and rodent liver where it inactivates steroid hormones and catalyzes a fundamental step in bile acid synthesis. Steroid hormones, including glucocorticoids, as well as bile acids are established regulators of metabolic phenotype. We have hypothesized that AKR1D1 plays a crucial regulatory role in hepatic metabolic homeostasis.<p class...

ea0037ep883 | Thyroid cancer | ECE2015

Aggressive medullary thyroid cancer in a homogenous population

Lennon Paul , Deedy Sandra , Green Andrew , Kinsella John , Timon Conrad , O'Neill James Paul , Healy Marie-Louise

Introduction: Medullary thyroid cancer arises from the calcitonin-secreting parafollicular C cells and consists of a spectrum of disease that ranges from extremely indolent tumours, where patients may survive for many years with a large tumor burden, to aggressive types associated with a high mortality rate. The objective of our study is to evaluate the prognostic factors and outcomes of patients diagnosed with medullary thyroid cancer in a homogenous population, and to examin...

ea0037ep1202 | Clinical Cases–Pituitary/Adrenal | ECE2015

Exaggerated cortisol response in heterozygous carriers with a mutation in the melanocortin-2 receptor (MC2R) gene

Kyithar Ma Pyeh , Green Andrew , Hughes Claire , Murphy Nuala , Byrne Maria

Introduction: Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disease characterised by ACTH resistance and isolated glucocorticoid deficiency. Mutations of ACTH receptor, known as melanocortin-2 receptor (MC2R), and melanocortin-2 receptor accessory protein (MRAP) account for approximately 25 and 15 to 20% of cases respectively. To date there is no strong evidence that heterozygous carriers have abnormal cortisol secretion.Case: We...

ea0032p984 | Thyroid (non-cancer) | ECE2013

Both Graves' disease and toxic nodular goiter are associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study

Brandt Frans , Thvilum Marianne , Almind Dorthe , Christensen Kaare , Green Anders , Hegedus Laszlo , Heiberg Brix Thomas

Background: Hyperthyroidism has been associated with increased all-cause mortality. Whether the underlying cause of hyperthyroidism influences this association is unclear. Our hypothesis was that Graves’ disease (GD) and toxic nodular goiter (TNG) differ with respect to mortality risk and cause of death.Methods: An observational cohort study, using record-linkage data from nation-wide Danish health registers. 1.291 and 861 subjects with GD and TNG, ...